Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wyeth Foreign Growth Strong While Alavert Sales Pick Up At Home

This article was originally published in The Tan Sheet

Executive Summary

Sales for Wyeth's non-sedating antihistamine Alavert (loratadine) more than quadrupled compared to the previous quarter
Advertisement

Related Content

Sales & Earnings In Brief
Sales & Earnings In Brief
Sales & Earnings In Brief
Loratadine Private Labelers Gain On Branded Alternatives
Wyeth Sees Alavert Sales Decline In Fourth Quarter Despite Good Year
Wyeth Sees Alavert Sales Decline In Fourth Quarter Despite Good Year

Topics

Advertisement
UsernamePublicRestriction

Register

PS096760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel